#qdengaindia
QDENGA Vaccine India: Age Limit, Doses and DCGI Approval
India Approves QDENGA Dengue Vaccine for People Aged 4–60 India has approved Takeda’s QDENGA as its first authorised dengue vaccine for people aged 4–60. The live-attenuated vaccine targets all four dengue virus serotypes and is administered in two doses, three months apart. India has approved QDENGA, making it the country’s first authorised vaccine for preventing dengue. The Drug Controller General of India has granted market authorisation for its use am
QDENGA Vaccine India: Age Limit, Doses and DCGI Approval
India Approves QDENGA Dengue Vaccine for People Aged 4–60 India has approved Takeda’s QDENGA as its first authorised dengue vaccine for people aged 4–60. The live-attenuated vaccine targets all four dengue virus serotypes and is administered in two doses, three months apart. India has approved QDENGA, making it the country’s first authorised vaccine for preventing dengue. The Drug Controller General of India has granted market authorisation for its use am









